Kaposi's sarcoma responding to topical imiquimod 5% cream: A case report

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Kaposi's sarcoma, a virus-associated neoplasm, can be treated with systemic therapy such interferon or chemotherapy, although a local alternative is possible in localized disease. Topical imiquimod is a ligand of the toll-like receptors 7 and 8 on dendritic cells, increasing immune responses and showing antiviral and antitumoral activities. We report a spectacular response to imiquimod 5% cream in a patient with classic Kaposi's sarcoma of the leg. © 2009 Benomar et al.; licensee Cases Network Ltd.

Cite

CITATION STYLE

APA

Benomar, S., Boutayeb, S., Benzekri, L., Errihani, H., & Hassam, B. (2009). Kaposi’s sarcoma responding to topical imiquimod 5% cream: A case report. Cases Journal, 2(9). https://doi.org/10.4076/1757-1626-2-7092

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free